Decreased Bleeding Frequency With Secondary Prophylactic Use Of NovoSeven (REG) Shown
Thu, 14 Dec 2006 03:00 AM EST
... Data presented at the 48th Annual Meeting of the American Society of Hematology (ASH) from a study testing the use of NovoSeven® Coagulation Factor VIIa (Recombinant) for secondary prophylaxis in patients with hemophilia complicated by inhibitors. [click link for full article] ...
Related Topics
- Factor VIIa, Recombinant
- Bleeding Disorders
- Gastrointestinal Bleeding
- Decreased tear production
- Decreased production tears
- Hearing Loss
- WISE EARS!® At Work!
- WISE EARS!® Campaign to Prevent NIHL
- WISE EARS!® Tips: Hearing Matters
- Hyperparathyroidism
- Amenorrhea
- Radiation Therapy
- Bleeding in the Digestive Tract
- Ulcers
- Ulcer
- Menstrual bleeding
- Excessive menstrual bleeding
- Hereditary Bleeding Disorders
- Pulmonary Hypertension
- Menorrhagia (heavy menstrual bleeding)

Not Signed In -


